EDGAR·FLOW

Vivani Medical, Inc. — Form 8-K

Filed November 16, 2026 · analyzed by the 8-K Agent
8-K ▲ Likely positive significance 48/100
What the filing says
Vivani Medical sold 5,049,506 shares at $1.01/share to two insiders: Gregg G Williams 2006 Irrevocable Trust ($5.0M for 4,950,496 shares) and Mendelsohn Family Enterprises LLC Profit Sharing Plan ($100K for 99,010 shares), closing ~Nov 23, 2026. Proceeds fund NPM-139 (semaglutide implant) development through Q3 2027; timing follows positive Phase 1 SLIM-1 trial results announced Nov 12, 2026. Share purchase agreement contains standard representations, 2-month lockup, and Nasdaq listing conditions.
Why this rating

Meaningful capital raise (11% of $45.9M market cap) from insiders; validates clinical progress but raises dilution concerns; moderate absolute event relative to company size.

View original filing on SEC.gov ↗ VANI · stock on Yahoo Finance ↗

See more from November 16, 2026.

EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.